急性脊髄損傷の世界市場レポート 2024年

急性脊髄損傷市場規模は近年力強く成長しています。2023年の63億2,000万米ドルから2024年には67億米ドルへと、CAGR6.1％で拡大します。実績期間の成長は、急性脊髄損傷の罹患率の上昇、急性脊髄損傷とその治療オプションに対する意識の高まり、個別化ケアに対する需要の高まり、可処分所得水準の上昇、急性脊髄損傷の研究開発に対する政府支出の増加などに起因しています。

臨床試験の増加は、急性脊髄損傷市場の拡大を促進すると予想されます。臨床試験は、急性脊髄損傷（SCI）の知識と治療法の選択肢を進歩させる上で重要な役割を果たしています。これらの臨床試験は、SCI患者における安全性と有効性を評価するために、新しい治療法、処置、介入を系統的に調査するものです。例えば、2023年5月17日現在、ClinicalTrials.govは、世界全体で45万2,604件の臨床試験が登録され、64,838件が積極的に参加者を求めていると報告しています。これは、2021年初頭に登録された約36万5,000件の臨床試験から大幅に増加したことを意味します。したがって、臨床試験数の増加は急性脊髄損傷市場の成長を促進する重要な要因となっています。

2023年の急性脊髄損傷市場で最大の地域は北米でした。急性脊髄損傷レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の急性脊髄損傷市場の促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の急性脊髄損傷の市場規模実績と成長、2018～2023年
• 世界の急性脊髄損傷市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の急性脊髄損傷市場、タイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 完全脊髄損傷
• 不完全脊髄損傷
• 世界の急性脊髄損傷市場、診断タイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 臨床検査
• 画像検査
• 世界の急性脊髄損傷市場、用途別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 病院
• クリニック

第7章 地域と国の分析

• 世界の急性脊髄損傷市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界の急性脊髄損傷市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 急性脊髄損傷市場の競合情勢
• 急性脊髄損傷市場の企業プロファイル
  • Pfizer Inc
  • AbbVie Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Biogen Inc.

第31章 その他の主要と革新的な企業

• Vertex Pharmaceuticals Inc
• Mitsubishi Tanabe Pharma Corporation
• Stanford Health Care
• BioMarin Pharmaceutical Inc.
• Neuralstem Inc
• Kennedy Krieger Institute
• Acorda Therapeutics Inc
• Craig Hospital
• Omeros Corporation
• Lineage Cell Therapeutics Inc
• Pharmazz Inc.
• Asterias Biotherapeutics Inc
• Histocell S.L.
• Athersys Inc.
• ReNetX Bio

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

“Acute Spinal Cord Injury Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on acute spinal cord injury market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for acute spinal cord injury? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The acute spinal cord injury market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Type: Complete Spinal Cord Injury; Incomplete Spinal Cord Injury
• 2) By Diagnosis Type: Laboratory Tests; Imaging Tests
• 3) By Application: Hospitals; Clinics
• Companies Mentioned: Pfizer Inc; AbbVie Inc.; Novartis AG; Teva Pharmaceutical Industries Ltd.; Biogen Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

An acute spinal cord injury (SCI) is a traumatic condition characterized by the potential occurrence of a spinal cord contusion (bruising), partial tearing, or complete transection (full severance) resulting from a traumatic event. Such injuries can lead to a significant reduction or complete loss of mobility, sensory perception, and organ function below the point of injury. Acute spinal cord injuries tend to be more prevalent among males and young adults, with causes ranging from motor vehicle accidents, falls, sports-related incidents, to complications arising from surgical procedures.

The primary categories of acute spinal cord injuries are complete and incomplete injuries. A complete spinal cord injury signifies the total absence of sensory and motor capabilities below the level of the injury. Medical professionals typically employ laboratory tests and various imaging procedures within hospital and clinical settings to diagnose these injuries.

The acute spinal cord injury market research report is one of a series of new reports from The Business Research Company that provides acute spinal cord injury market statistics, including acute spinal cord injury industry global market size, regional shares, competitors with a acute spinal cord injury market share, detailed acute spinal cord injury market segments, market trends and opportunities and any further data you may need to thrive in the acute spinal cord injury industry. This acute spinal cord injury market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The acute spinal cord injury market size has grown strongly in recent years. It will grow from $6.32 billion in 2023 to $6.7 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to rising incidence of acute spinal cord injuries, increasing awareness of acute spinal cord injury's and their treatment options, growing demand for personalized care, rising disposable income levels, increasing government spending on asci research and development.

The acute spinal cord injury market size is expected to see strong growth in the next few years. It will grow to $8.25 billion in 2028 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to emerging therapies, telemedicine adoption, patient-centric care models, increasing focus on preventive healthcare and injury prevention. Major trends in the forecast period include medical advancements, rehabilitation techniques, neuroprotection therapies, psychosocial support, advocacy and accessibility.

The acute spinal cord injury market is poised for growth due to the increasing frequency of road accidents. Road accidents refer to incidents involving motor vehicle collisions that result in injuries or fatalities. These accidents can inflict harm on the central nervous system (CNS), disrupting the transmission of nerves essential for sensory and functional abilities. The force of impact during an accident can lead to trauma in the cervical, lumbar, or thoracic spine, potentially causing damage or severing the spinal cord and resulting in paralysis. For instance, in August 2022, data from the National Highway Traffic Safety Administration, a US government agency, revealed a 7% increase in traffic accident-related fatalities, with 9,560 individuals losing their lives in the first quarter of 2022 compared to 8,935 fatalities during the same period in 2021. Consequently, the upsurge in road accidents is a driving force behind the growth of the acute spinal cord injury market.

The growing number of clinical trials is expected to drive the expansion of the acute spinal cord injury market. Clinical trials play a vital role in advancing our knowledge and treatment options for Acute Spinal Cord Injury (SCI). These trials systematically investigate new therapies, treatments, or interventions to evaluate their safety and effectiveness in SCI patients. For example, as of May 17, 2023, ClinicalTrials.gov reported 452,604 globally registered clinical studies, with 64,838 actively seeking participants. This represents a significant increase from the approximately 365,000 registered trials in early 2021. Hence, the increasing number of clinical trials is a key factor fueling the growth of the acute spinal cord injury market.

The high cost of treatment is anticipated to impede the growth of the acute spinal cord injury market in the future. Treatment expenses can be a substantial financial burden for patients and their families, potentially limiting access to essential care. For example, data from July 2022, provided by the National Library of Medicine, a US-based biomedical library, indicates that the direct cost of treating spinal cord injuries can range from $290 to $612,590. Inpatient rehabilitation costs fall within a range of $19,360 to $443,040, while the first year post-injury can cost between $32,240 and $1,156,400. Consequently, the high cost of treatment remains a significant challenge in the acute spinal cord injury market.

Prominent companies operating in this space are dedicated to creating innovative medications to better serve their patients and maintain their market positions. The development of novel drugs, such as LYVISPAH, has the potential to improve treatment outcomes, particularly through combination therapy. For instance, in July 2022, Amneal Pharmaceuticals, a US-based pharmaceutical firm, introduced LYVISPAH, an FDA-approved baclofen oral granule available in 5 mg, 10 mg, and 20 mg doses. LYVISPAH is designed to treat spasticity associated with multiple sclerosis and other spinal cord disorders, addressing issues like flexor spasms, related pain, muscle rigidity, and spasticity. It offers flexible dosing options and is bioequivalent to oral baclofen tablets, potentially benefiting patients with spinal cord injuries and related conditions.

In February 2023, Globus Medical Inc., a US-based company specializing in musculoskeletal device solutions, completed the acquisition of NuVasive Inc. for $3.1 billion. This strategic move empowered Globus Medical to strengthen and expand its portfolio in musculoskeletal disorder devices, positioning it as a leading company in musculoskeletal technology. NuVasive Inc. is a US-based firm known for its development of medical devices and procedures for minimally invasive spinal cord surgery.

Major players in the acute spinal cord injury market are Pfizer Inc., AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Biogen Inc., Vertex Pharmaceuticals Inc., Mitsubishi Tanabe Pharma Corporation, Stanford Health Care, BioMarin Pharmaceutical Inc., Neuralstem Inc., Kennedy Krieger Institute, Acorda Therapeutics Inc., Craig Hospital, Omeros Corporation, Lineage Cell Therapeutics Inc., Pharmazz Inc., Asterias Biotherapeutics Inc., Histocell S.L., Athersys Inc., ReNetX Bio, Kringle Pharma Inc., BioArctic AB, BioAxone BioSciences Inc., InVivo Therapeutics Holdings Corp, Geron Corporation, Neuronax SA, Tenax Therapeutics, Eusol Biotech Co. Ltd.

North America was the largest region in the acute spinal cord injury market in 2023. The regions covered in acute spinal cord injury report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the acute spinal cord injury market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The acute spinal cord injury market include revenues earned through entities by types such as complete spinal cord injury and incomplete spinal cord injury. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Acute Spinal Cord Injury Market Characteristics

3. Acute Spinal Cord Injury Market Trends And Strategies

4. Acute Spinal Cord Injury Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Acute Spinal Cord Injury Market Size and Growth

• 5.1. Global Acute Spinal Cord Injury Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Acute Spinal Cord Injury Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Acute Spinal Cord Injury Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Acute Spinal Cord Injury Market Segmentation

• 6.1. Global Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Complete Spinal Cord Injury
• Incomplete Spinal Cord Injury
• 6.2. Global Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Laboratory Tests
• Imaging Tests
• 6.3. Global Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Clinics

7. Acute Spinal Cord Injury Market Regional And Country Analysis

• 7.1. Global Acute Spinal Cord Injury Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Acute Spinal Cord Injury Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Acute Spinal Cord Injury Market

• 8.1. Asia-Pacific Acute Spinal Cord Injury Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Acute Spinal Cord Injury Market

• 9.1. China Acute Spinal Cord Injury Market Overview
• 9.2. China Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Acute Spinal Cord Injury Market

• 10.1. India Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Acute Spinal Cord Injury Market

• 11.1. Japan Acute Spinal Cord Injury Market Overview
• 11.2. Japan Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Acute Spinal Cord Injury Market

• 12.1. Australia Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Acute Spinal Cord Injury Market

• 13.1. Indonesia Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Acute Spinal Cord Injury Market

• 14.1. South Korea Acute Spinal Cord Injury Market Overview
• 14.2. South Korea Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Acute Spinal Cord Injury Market

• 15.1. Western Europe Acute Spinal Cord Injury Market Overview
• 15.2. Western Europe Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Acute Spinal Cord Injury Market

• 16.1. UK Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Acute Spinal Cord Injury Market

• 17.1. Germany Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Acute Spinal Cord Injury Market

• 18.1. France Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Acute Spinal Cord Injury Market

• 19.1. Italy Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Acute Spinal Cord Injury Market

• 20.1. Spain Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Acute Spinal Cord Injury Market

• 21.1. Eastern Europe Acute Spinal Cord Injury Market Overview
• 21.2. Eastern Europe Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Acute Spinal Cord Injury Market

• 22.1. Russia Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Acute Spinal Cord Injury Market

• 23.1. North America Acute Spinal Cord Injury Market Overview
• 23.2. North America Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Acute Spinal Cord Injury Market

• 24.1. USA Acute Spinal Cord Injury Market Overview
• 24.2. USA Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Acute Spinal Cord Injury Market

• 25.1. Canada Acute Spinal Cord Injury Market Overview
• 25.2. Canada Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Acute Spinal Cord Injury Market

• 26.1. South America Acute Spinal Cord Injury Market Overview
• 26.2. South America Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Acute Spinal Cord Injury Market

• 27.1. Brazil Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Acute Spinal Cord Injury Market

• 28.1. Middle East Acute Spinal Cord Injury Market Overview
• 28.2. Middle East Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Acute Spinal Cord Injury Market

• 29.1. Africa Acute Spinal Cord Injury Market Overview
• 29.2. Africa Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Acute Spinal Cord Injury Market Competitive Landscape And Company Profiles

• 30.1. Acute Spinal Cord Injury Market Competitive Landscape
• 30.2. Acute Spinal Cord Injury Market Company Profiles
  • 30.2.1. Pfizer Inc
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. AbbVie Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Novartis AG
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Teva Pharmaceutical Industries Ltd.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Biogen Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Acute Spinal Cord Injury Market Other Major And Innovative Companies

• 31.1. Vertex Pharmaceuticals Inc
• 31.2. Mitsubishi Tanabe Pharma Corporation
• 31.3. Stanford Health Care
• 31.4. BioMarin Pharmaceutical Inc.
• 31.5. Neuralstem Inc
• 31.6. Kennedy Krieger Institute
• 31.7. Acorda Therapeutics Inc
• 31.8. Craig Hospital
• 31.9. Omeros Corporation
• 31.10. Lineage Cell Therapeutics Inc
• 31.11. Pharmazz Inc.
• 31.12. Asterias Biotherapeutics Inc
• 31.13. Histocell S.L.
• 31.14. Athersys Inc.
• 31.15. ReNetX Bio

32. Global Acute Spinal Cord Injury Market Competitive Benchmarking

33. Global Acute Spinal Cord Injury Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Acute Spinal Cord Injury Market

35. Acute Spinal Cord Injury Market Future Outlook and Potential Analysis

• 35.1 Acute Spinal Cord Injury Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Acute Spinal Cord Injury Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Acute Spinal Cord Injury Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer